The U.S. FDA has announced a nationwide recall of 15 varieties of cough drops and suppressants sold under brands including Exchange Select, Caring Mill, and Q-C Quality Choice, due to quality concerns identified during an inspection of the Chinese manufacturer. Separately, Morovan gel nail polish remover sold on Amazon is being recalled for containing chemicals banned in cosmetics. These actions signal heightened regulatory scrutiny on imported consumer chemical products, relevant to overseas buyers in the personal-care and OTC pharmaceutical supply chain.
Recall details for cough drops
The FDA classified the cough drop recall as Class Two, indicating that any health risks are expected to be temporary or medically reversible. The affected products were manufactured in China and distributed nationwide in the U.S. Consumers are advised to check packaging and lot numbers before use. The specific quality issues were not disclosed, but the recall is voluntary.
Nail product recall for banned chemicals
Morovan gel nail polish remover, sold on Amazon, is being recalled after testing revealed the presence of chemicals prohibited in cosmetics. Approximately 4,000 units were sold between August and January. No injuries have been reported to date. Consumers are instructed to stop using the product immediately and contact the company for a refund.
Compliance and logistics signals for buyers
These recalls underscore the FDA's active enforcement of quality and chemical safety standards for imported products. For overseas distributors and formulators in the personal-care and OTC sectors, this serves as a reminder to verify raw material compliance with U.S. cosmetic regulations and to maintain robust quality assurance documentation. Supply-chain partners should review supplier audit reports and ensure banned substances are excluded from formulations.
China sourcing context
The cough drop recall highlights ongoing FDA scrutiny of Chinese-manufactured OTC products. Importers and trading companies should anticipate more frequent inspections and potential delays. For nail care products, the presence of banned chemicals suggests gaps in ingredient verification. Buyers sourcing from China are advised to request certificates of analysis and third-party testing for restricted substances to mitigate regulatory risks.
Source: Read the original report | Published: May 04, 2026